CELF4 and endometrial cancer: Two hypermethylated candidate genes, namely, cysteine dioxygenase type 1 (CDO1) and CUGBP Elav-like family member 4 (CELF4), have been identified as potential biomarkers for endometrial cancer (33, 37–39).